December 1, 2023
Antibody-drug conjugates have proven to be a versatile and effective tool in treating a wide range of tumor types, establishing the drug class as a valuable weapon against cancer. The approval of…
November 30, 2023
November 29, 2023
November 29, 2023
November 29, 2023
Scleroderma, also known as systemic sclerosis (SSc), is a rare, progressive, and debilitating autoimmune disorder characterized by skin fibrosis, systemic inflammation, and vasculopathy that…
November 28, 2023
November 22, 2023
November 22, 2023
November 22, 2023
November 21, 2023
November 17, 2023
November 17, 2023
Biologics approved to treat immune indications (e.g., rheumatoid arthritis, Crohn’s disease) are among the most commercially successful biopharmaceutical products and offer a great opportunity to…